JP2018518151A5 - - Google Patents

Info

Publication number

JP2018518151A5

JP2018518151A5 JP2017550485A JP2017550485A JP2018518151A5 JP 2018518151 A5 JP2018518151 A5 JP 2018518151A5 JP 2017550485 A JP2017550485 A JP 2017550485A JP 2017550485 A JP2017550485 A JP 2017550485A JP 2018518151 A5 JP2018518151 A5 JP 2018518151A5

Authority

JP

Japan

Prior art keywords

seq

antibody

acid sequence

isolated

amino acid

Prior art date

2016-03-25

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Withdrawn

Links

• Espacenet
• Global Dossier
• Discuss

• 108010079206 V-Set Domain-Containing T-Cell Activation Inhibitor 1 Proteins 0.000 claims description 49
• 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims description 39
• 238000000034 method Methods 0.000 claims description 39
• 206010028980 Neoplasm Diseases 0.000 claims description 37
• 210000004027 cell Anatomy 0.000 claims description 37
• 150000001413 amino acids Chemical class 0.000 claims description 30
• 150000007523 nucleic acids Chemical group 0.000 claims description 29
• 239000000523 sample Substances 0.000 claims description 27
• 239000000427 antigen Substances 0.000 claims description 21
• 102000036639 antigens Human genes 0.000 claims description 21
• 108091007433 antigens Proteins 0.000 claims description 21
• 108020004707 nucleic acids Proteins 0.000 claims description 19
• 102000039446 nucleic acids Human genes 0.000 claims description 19
• 201000011510 cancer Diseases 0.000 claims description 16
• 239000012634 fragment Substances 0.000 claims description 15
• 108060003951 Immunoglobulin Proteins 0.000 claims description 12
• 102000018358 immunoglobulin Human genes 0.000 claims description 12
• 108091033319 polynucleotide Proteins 0.000 claims description 12
• 102000040430 polynucleotide Human genes 0.000 claims description 12
• 239000002157 polynucleotide Substances 0.000 claims description 12
• 239000012472 biological sample Substances 0.000 claims description 11
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 claims description 10
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 10
• 229920001184 polypeptide Polymers 0.000 claims description 10
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 10
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 10
• 238000002560 therapeutic procedure Methods 0.000 claims description 10
• 239000013598 vector Substances 0.000 claims description 10
• 230000000295 complement effect Effects 0.000 claims description 9
• 206010006187 Breast cancer Diseases 0.000 claims description 8
• 208000026310 Breast neoplasm Diseases 0.000 claims description 8
• 208000006332 Choriocarcinoma Diseases 0.000 claims description 8
• 206010009944 Colon cancer Diseases 0.000 claims description 8
• 208000029742 colonic neoplasm Diseases 0.000 claims description 8
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 6
• 238000003364 immunohistochemistry Methods 0.000 claims description 6
• 230000001575 pathological effect Effects 0.000 claims description 6
• 230000011664 signaling Effects 0.000 claims description 6
• 238000009396 hybridization Methods 0.000 claims description 5
• 241000124008 Mammalia Species 0.000 claims description 4
• 206010060862 Prostate cancer Diseases 0.000 claims description 4
• 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 4
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 4
• 230000000139 costimulatory effect Effects 0.000 claims description 4
• 210000000822 natural killer cell Anatomy 0.000 claims description 4
• 238000002965 ELISA Methods 0.000 claims description 3
• 206010033128 Ovarian cancer Diseases 0.000 claims description 3
• 206010061535 Ovarian neoplasm Diseases 0.000 claims description 3
• 238000001514 detection method Methods 0.000 claims description 3
• 238000000684 flow cytometry Methods 0.000 claims description 3
• 238000011534 incubation Methods 0.000 claims description 3
• 239000003550 marker Substances 0.000 claims description 3
• 230000004614 tumor growth Effects 0.000 claims description 3
• 238000001262 western blot Methods 0.000 claims description 3
• 241000282465 Canis Species 0.000 claims description 2
• 241000282693 Cercopithecidae Species 0.000 claims description 2
• 108091035707 Consensus sequence Proteins 0.000 claims description 2
• 241000282324 Felis Species 0.000 claims description 2
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 claims description 2
• 101000955999 Homo sapiens V-set domain-containing T-cell activation inhibitor 1 Proteins 0.000 claims description 2
• 241001494479 Pecora Species 0.000 claims description 2
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 claims description 2
• 239000003242 anti bacterial agent Substances 0.000 claims description 2
• 230000003115 biocidal effect Effects 0.000 claims description 2
• 102000055298 human VTCN1 Human genes 0.000 claims description 2
• 230000002401 inhibitory effect Effects 0.000 claims description 2
• 230000005764 inhibitory process Effects 0.000 claims description 2
• 239000003446 ligand Substances 0.000 claims description 2
• 238000004519 manufacturing process Methods 0.000 claims description 2
• 239000013612 plasmid Substances 0.000 claims description 2
• 210000001519 tissue Anatomy 0.000 claims description 2
• 230000002463 transducing effect Effects 0.000 claims description 2
• 210000004881 tumor cell Anatomy 0.000 claims description 2
• 238000011144 upstream manufacturing Methods 0.000 claims description 2
• 125000003275 alpha amino acid group Chemical group 0.000 claims 17
• 238000000338 in vitro Methods 0.000 claims 2
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims 1
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims 1
• 241000713666 Lentivirus Species 0.000 claims 1
• 230000005907 cancer growth Effects 0.000 claims 1
• 210000001672 ovary Anatomy 0.000 claims 1
• 238000005406 washing Methods 0.000 claims 1
• 241000283690 Bos taurus Species 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• 241000699670 Mus sp. Species 0.000 description 1
• 238000000746 purification Methods 0.000 description 1